Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.03x is 100% below its 5-year average of 57.43x, near the low end of its 5-year range (-112.36x–1669.75x).
As of the fiscal period ended Sunday, March 31, 2019. 99.89% above its 12-month average of -25.82x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2019 (2019-03-31): -0.03x.
INTEREST COVERAGE RATIO
-0.03x
INTEREST COVERAGE RATIO AVG TTM
-25.82x
INTEREST COVERAGE RATIO AVG 3Y
78.09x
INTEREST COVERAGE RATIO AVG 5Y
57.43x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+99.89%
CURRENT VS 3Y AVG
-100.04%
CURRENT VS 5Y AVG
-100.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+99.49%
vs the sector median at left
Larimar Therapeutics, Inc.
Market Cap
$297.62M
Interest Coverage Ratio
-0.03x
TTM Avg
-25.82x
3Y Avg
78.09x
5Y Avg
57.43x
Market Cap
$303.53M
Interest Coverage Ratio
N/A
TTM Avg
12.71x
3Y Avg
12.71x
5Y Avg
12.71x
Market Cap
$290.97M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$289.25M
Interest Coverage Ratio
-23.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$309.62M
Interest Coverage Ratio
-47.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$284.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.60M
Interest Coverage Ratio
-25.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | $297.62M | -0.03x | -25.82x | 78.09x | 57.43x |
| Benitec Biopharma Inc. (BNTC)vs › | $303.53M | N/A | 12.71x | 12.71x | 12.71x |
| Standard BioTools Inc. (LAB)vs › | $290.97M | -3588.65x | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | -23.92x | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | N/A | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.62M | -47.93x | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $284.21M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | -25.79x | 0.59x | 0.59x | 0.59x |
| Fate Therapeutics, Inc. (FATE)vs › | $278.87M | N/A | N/A | N/A | N/A |
Interest Coverage
-0.0x
Debt/Equity
0.04
Current Ratio
4.70
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-03-31 | -0.03x |
| 2018-12-31 | -29.44x |
| 2018-09-30 | -31.93x |
| 2018-06-30 | -33.39x |
| 2018-03-31 | -34.28x |
| 2017-12-31 | 1669.75x |
| 2017-09-30 | 414.19x |
| 2017-06-30 | 255.40x |
| 2017-03-31 | 181.71x |
| 2016-12-31 | 107.99x |
| 2016-09-30 | -112.36x |
| 2016-06-30 | 107.59x |
| 2016-03-31 | 111.61x |
| 2015-12-31 | 129.14x |
| 2015-09-30 | 98.58x |
| 2015-06-30 | 82.68x |
| 2015-03-31 | 62.16x |
| 2014-09-30 | 67.42x |
| 2014-06-30 | 13.51x |
